Loading company…
YJ Cerapeutics develops neural stem cell therapies for chronic spinal cord injuries.
YJ Cerapeutics develops neural progenitor cell treatments using small-molecule direct conversion technology, with a focus on chronic spinal cord injury. Based in Seoul, South Korea, the company raised KRW 7 billion in venture funding in July 2022 from Quad Asset Management, Ryukyung PSG Asset Management, and Saehan Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in